Rossari Biotech Ltd. | Small-cap | Basic Materials
₹682.35
0.53%
| Rossari Biotech Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 20.7B
Gross Profit 6.2B 30.02%
Operating Income 1.9B 9.05%
Net Income 1.4B 6.58%

Balance Sheet Metrics

Total Assets 19.0B
Total Liabilities 7.1B
Shareholders Equity 11.9B
Debt to Equity 0.60

Cash Flow Metrics

Operating Cash Flow 440.1M
Free Cash Flow -210.7M

Revenue & Profitability Trend

Rossari Biotech Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 20.7B 18.3B 16.5B 14.8B 7.1B
Cost of Goods Sold 14.5B 13.0B 11.8B 11.1B 4.7B
Gross Profit 6.2B 5.2B 4.7B 3.6B 2.4B
Operating Expenses 2.1B 1.5B 1.4B 1.0B 619.9M
Operating Income 1.9B 1.8B 1.5B 1.3B 1.0B
Pre-tax Income 1.9B 1.8B 1.4B 1.4B 1.1B
Income Tax 488.1M 469.3M 369.6M 385.8M 267.9M
Net Income 1.4B 1.3B 1.1B 977.0M 800.5M
EPS (Diluted) - ₹23.62 ₹19.38 ₹17.70 ₹15.47

Income Statement Trend

Rossari Biotech Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 10.4B 8.4B 7.2B 6.1B 3.5B
Non-Current Assets 8.5B 7.3B 6.5B 6.5B 2.1B
Total Assets 19.0B 15.7B 13.7B 12.6B 5.6B
Liabilities
Current Liabilities 5.4B 4.2B 3.5B 2.9B 1.5B
Non-Current Liabilities 1.7B 996.9M 1.0B 1.6B 23.9M
Total Liabilities 7.1B 5.2B 4.5B 4.5B 1.5B
Equity
Total Shareholders Equity 11.9B 10.5B 9.2B 8.1B 4.1B

Balance Sheet Composition

Rossari Biotech Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 1.9B 1.8B 1.4B 1.4B 1.1B
Operating Cash Flow 440.1M -114.2M 1.4B 550.4M 347.2M
Investing Activities
Capital Expenditures -1.6B -1.3B -311.9M -363.1M -559.0M
Investing Cash Flow -1.6B -1.4B -1.3B -3.0B -407.1M
Financing Activities
Dividends Paid -27.6M -27.6M -27.5M -27.5M -25.4M
Financing Cash Flow 844.5M 329.9M 669.6M 2.9B -477.5M
Free Cash Flow -210.7M -880.3M 1.2B -88.7M -103.2M

Cash Flow Trend

Rossari Biotech Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 27.06
Forward P/E 19.89
Price to Book 3.12
Price to Sales 1.78
PEG Ratio 19.89

Profitability Ratios

Profit Margin 6.56%
Operating Margin 6.98%
Return on Equity 12.21%
Return on Assets 6.75%

Financial Health

Current Ratio 1.94
Debt to Equity 18.39
Beta 0.26

Per Share Data

EPS (TTM) ₹24.65
Book Value per Share ₹214.12
Revenue per Share ₹376.13

Financial data is updated regularly. All figures are in the company's reporting currency.